18,035 Encompass Health Corporation $EHC Shares Purchased by Candriam S.C.A.

Candriam S.C.A. raised its stake in Encompass Health Corporation (NYSE:EHC) by 26.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 86,035 shares of the company’s stock after buying an additional 18,035 shares during the period. Candriam S.C.A.’s holdings in Encompass Health were worth $10,491,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the stock. Ethic Inc. raised its position in shares of Encompass Health by 25.7% during the third quarter. Ethic Inc. now owns 11,470 shares of the company’s stock worth $1,393,000 after acquiring an additional 2,347 shares during the last quarter. Pictet Asset Management Holding SA boosted its holdings in Encompass Health by 0.8% in the third quarter. Pictet Asset Management Holding SA now owns 16,037 shares of the company’s stock valued at $1,948,000 after acquiring an additional 128 shares during the last quarter. Parallel Advisors LLC boosted its holdings in Encompass Health by 7.5% in the third quarter. Parallel Advisors LLC now owns 2,381 shares of the company’s stock valued at $289,000 after acquiring an additional 167 shares during the last quarter. CenterBook Partners LP acquired a new stake in Encompass Health during the 3rd quarter valued at approximately $394,000. Finally, Heritage Family Offices LLP acquired a new stake in Encompass Health during the 3rd quarter valued at approximately $62,000. Institutional investors own 97.25% of the company’s stock.

Insider Transactions at Encompass Health

In related news, EVP John Darby sold 4,858 shares of the stock in a transaction on Monday, August 31st. The shares were sold at an average price of $121.09, for a total transaction of $588,255.22. Following the transaction, the executive vice president directly owned 75,041 shares of the company’s stock, valued at $9,086,714.69. This represents a 6.08% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.80% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the stock. UBS Group raised their price target on shares of Encompass Health from $155.00 to $165.00 and gave the stock a “buy” rating in a report on Friday, October 30th. Raymond James Financial reaffirmed a “strong-buy” rating and issued a $155.00 price objective on shares of Encompass Health in a research note on Friday, October 30th. KeyCorp increased their price objective on shares of Encompass Health from $147.00 to $150.00 and gave the stock an “overweight” rating in a research report on Friday, October 30th. Mizuho set a $155.00 target price on shares of Encompass Health in a research note on Monday, November 2nd. Finally, Truist Financial restated a “buy” rating and issued a $156.00 target price (up from $150.00) on shares of Encompass Health in a report on Friday, October 30th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and one has given a Hold rating to the company. According to MarketBeat, Encompass Health currently has an average rating of “Buy” and an average price target of $154.25.

Encompass Health Trading Up 2.4%

Shares of EHC stock opened at $140.79 on Tuesday. Encompass Health Corporation has a fifty-two week low of $92.77 and a fifty-two week high of $143.36. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.19 and a current ratio of 1.09. The stock has a 50 day simple moving average of $125.10 and a two-hundred day simple moving average of $111.14. The company has a market cap of $13.81 billion, a P/E ratio of 22.00, a PEG ratio of 2.46 and a beta of 0.83.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Wednesday, October 28th. The company reported $1.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.36 by $0.16. The firm had revenue of $1.61 billion for the quarter, compared to analysts’ expectations of $1.60 billion. Encompass Health had a return on equity of 18.35% and a net margin of 10.17%. The company’s revenue for the quarter was up 8.9% compared to the same quarter last year. During the same period in the prior year, the business earned $1.23 EPS. Research analysts forecast that Encompass Health Corporation will post 6.26 earnings per share for the current year.

Encompass Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 15th. Investors of record on Monday, January 4th will be given a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Monday, January 4th. Encompass Health’s payout ratio is presently 13.12%.

About Encompass Health

Encompass Health Corporation is a U.S. healthcare provider focused on inpatient rehabilitation. The company operates rehabilitation hospitals that offer specialized care for people recovering from conditions such as strokes, brain and spinal cord injuries, orthopedic conditions, and other illnesses or injuries.

Its hospitals provide coordinated rehabilitation services, including physical, occupational, and speech therapy, alongside medical care. Encompass Health serves patients through facilities across the United States.

The company was previously known as HealthSouth and adopted the Encompass Health name in 2018.